AbbVie traded at $160.70 this Friday May 31st, increasing $4.56 or 2.92 percent since the previous trading session. Looking back, over the last four weeks, AbbVie gained 0.80 percent. Over the last 12 months, its price rose by 20.43 percent. Looking ahead, we forecast AbbVie to be priced at 162.62 by the end of this quarter and at 157.93 in one year, according to Trading Economics global macro models projections and analysts expectations.